Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 12, 2022

SELL
$17.64 - $39.57 $414,540 - $929,895
-23,500 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$34.2 - $47.56 $803,700 - $1.12 Million
23,500 New
23,500 $80,000
Q1 2021

May 14, 2021

SELL
$38.75 - $86.92 $5.55 Million - $12.4 Million
-143,100 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$34.61 - $123.66 $4.95 Million - $17.7 Million
143,100 New
143,100 $318,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $450M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.